Explorium Logo

Chelsea Therapeutics logo

chelsearx.com

3530 Toringdon Way Suite 200 Charlotte, NC 28277, US

Chelsea Therapeutics

Chelsea Therapeutics was a biopharmaceutical company specializing in the development of innovative products that addressed important unmet medical needs or offered alternatives to existing treatments. Chelsea's novel medication, Northera (droxidopa) for symptomatic neurogenic orthostatic hypotension was approved by the FDA in February 2014. The company was acquired by Lundbeck in June 2014.

Chelsea Therapeutics logo

Chelsea Therapeutics

Chelsea Therapeutics was a biopharmaceutical company specializing in the development of innovative products that addressed important unmet medical needs or offered alternatives to existing treatments. Chelsea's novel medication, Northera (droxidopa) for symptomatic neurogenic orthostatic hypotension was approved by the FDA in February 2014. The company was acquired by Lundbeck in June 2014.

chelsearx.com

3530 Toringdon Way Suite 200 Charlotte, NC 28277, US

Details

Year founded

2004

Revenue

5M-10M

Employees

11-50

Number of locations

1

NAICS

3254

SIC

2834

Products & Services

Outlines the company's specialized services and operational strengths.

  • Biopharmaceuticals
  • Neurologic disorders treatment
  • Pharmaceuticals
  • Contact us in order to access

Equipment

Provides a detailed list of machinery and tools utilized on the company's premises.

  • The Back Attack™
  • Leverage Mid Row
  • Standing Chest Press Machine
  • Contact us in order to access

Ramping up production

Indicates the company's current production trend and growth trajectory.

FALSE

Our production algorithm is showing that chelsea therapeutics is not ramping up production.

Target industries

Medical

Employees working in Chelsea Therapeutics

Arthur Hewitt

Chief scientific officer medical affairs

Joe Oliveto

Vice president operations

Marilyn Gill

Senior therapist

Oluwafemi Ojugbele

Worker

Mary Leuchars

Medical science liaison

Employees working in Chelsea Therapeutics

Arthur Hewitt

Chief scientific officer medical affairs

Joe Oliveto

Vice president operations

Marilyn Gill

Senior therapist

Oluwafemi Ojugbele

Worker

Mary Leuchars

Medical science liaison

Book a demo

Locations (1)

Chelsea Therapeutics

3530 Toringdon Way Suite 200 Charlotte, NC 28277, US

Frequently Asked Questions


Chelsea Therapeutics offers a range of services and capabilities, including Biopharmaceuticals.


Get the full services & capabilities list of Chelsea Therapeutics

Chelsea Therapeutics uses a variety of equipment, including The Back Attack™.


Get the full equipment list of Chelsea Therapeutics

Chelsea Therapeutics serves several industries, including the medical industry.


Get the full target industries list of Chelsea Therapeutics

Chelsea Therapeutics operates from a single location at 3530 toringdon way suite 200, charlotte, north carolina 28277, united states.


Get a free locations and target markets review for Chelsea Therapeutics

The headquarters of Chelsea Therapeutics are located in 3530 toringdon way suite 200, charlotte, north carolina 28277, united states.


Get a free locations and target markets review for Chelsea Therapeutics

The NAICS code for Chelsea Therapeutics is 3254.


Get a free business data review for Chelsea Therapeutics

Chelsea Therapeutics has 12 employees.


Get a free workforce data review of Chelsea Therapeutics

The official website of Chelsea Therapeutics is https://www.chelsearx.com/.


Chelsea Therapeutics was founded in 2004.